Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2009-10-23 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport 1 januari – 30 september 2009' (Interim Report for the period Jan 1 – Sep 30, 2009). It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and detailed management commentary on business segments (Medicinteknik and Precisionsteknik). It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2009
2009-10-23 Swedish
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'Pressrelease' and announces the launch of two new products by a subsidiary (Elos Fixturlaser) at an upcoming trade show (Tekniska Mässan). It contains quotes from management (CEO Göran Brorsson) and contact information typical of a corporate news announcement. This type of general, non-periodic, non-regulatory announcement that doesn't fit specific financial report categories (like 10-K, ER, IR) or specific corporate actions (like DIV, CAP, DIRS) is best classified as a general Regulatory Filing or announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release announcing product news, especially since it is not a formal financial report or a specific corporate action filing.
2009-10-12 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport 1 januari – 30 juni 2009' (Interim Report for the period January 1 – June 30, 2009). It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, segment reporting (Medicinteknik and Precisionsteknik), and management commentary on business performance. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2009
2009-08-20 Swedish
AGM Information 2009
AGM Information Classification · 99% confidence The document is explicitly titled "Pressrelease från årsstämma med Elos AB" (Press release from the Annual General Meeting with Elos AB) and details decisions made during the AGM, such as the election of a new chairman (Stig-Arne Blom), dividend approval (1:50 per share), and changes to the board composition. This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). Although it mentions a dividend (DIV) and management changes (MANG), the overarching context is the AGM summary.
2009-04-30 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January – 31 March 2009. It contains comprehensive financial statements, including income statements, balance sheet data, management commentary, and analysis of business segments (Medicinteknik and Precisionsteknik). It is not a mere announcement or certification, but the full quarterly report itself, fitting the definition of an Interim/Quarterly Report (IR). Q1 2009
2009-04-29 Swedish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for 'Nordea Fonder Finland Ab' concerning 'Elos Medtech AB'. It explicitly states the 'Reason for major shareholding notification Sell' and provides the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages (e.g., 4.99%). This structure is characteristic of a notification regarding a change in significant ownership thresholds. Based on the provided definitions, this aligns perfectly with the Major Shareholding Notification category (MRQ). The document length is short (2489 chars), but the content is the notification itself, not an announcement of a report, thus ruling out RPA/RNS based on content type.
2009-04-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.